 Coherus BioSciences, Inc. NASDAQ:CHRS Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Marek Ciszewski - Senior Vice President, Investor Relations Denny Lanfear - Chief Executive Officer Theresa Lavallee - Chief Development Officer Rosh Dias - Chief Medical Officer Paul Reider - Chief Commercial Officer McDavid Stilwell - Chief Financial Officer Conference Call Participants Salim Syed - Mizuho Douglas Tsao - HC Wainwright Georgi Yordanov - Cowen Steve Boland - Bank of America Chris Schott - JPMorgan Ash Verma - UBS Operator Good day and thank you for standing by. Welcome to the Coherus Biosciences Inc. Q3 2022 Conference Call. 